Cargando…

The Level of Oxidative Neutrophil Response When Determining Endotoxin Activity Assay: A New Biomarker for Defining the Indications and Effectiveness of Intensive Care in Patients with Sepsis

Background. To analyse the clinical informativity of the neutrophil oxidative response level (“Response”) during an Endotoxin Activity Assay (EAA) as a new biomarker defining the indications and effectiveness of intensive care in cardiac surgical patients with septic complications. Methods. Blood sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaroustovsky, Michael, Rogalskaya, Ekaterina, Plyushch, Marina, Klimovich, Ludmila, Samsonova, Nataliya, Abramyan, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405379/
https://www.ncbi.nlm.nih.gov/pubmed/28487809
http://dx.doi.org/10.1155/2017/3495293
_version_ 1783231754145890304
author Yaroustovsky, Michael
Rogalskaya, Ekaterina
Plyushch, Marina
Klimovich, Ludmila
Samsonova, Nataliya
Abramyan, Marina
author_facet Yaroustovsky, Michael
Rogalskaya, Ekaterina
Plyushch, Marina
Klimovich, Ludmila
Samsonova, Nataliya
Abramyan, Marina
author_sort Yaroustovsky, Michael
collection PubMed
description Background. To analyse the clinical informativity of the neutrophil oxidative response level (“Response”) during an Endotoxin Activity Assay (EAA) as a new biomarker defining the indications and effectiveness of intensive care in cardiac surgical patients with septic complications. Methods. Blood samples were taken from 198 adult patients who were admitted to the ICU after cardiac surgery (SIRS: 34, MODS: 36, and sepsis: 128). The composite of laboratory studies included CRP, PCT, EAA with “Response” level, and presepsin. Results. 83% of patients had a “normal” neutrophil response, 12% of patients had a low neutrophil response, and 5% of patients had a critically low neutrophil response. Patients with critically low responses had the lowest values of the EAA and the highest concentrations of PSP and D-dimer (p < 0.05). Conclusions. EAA results should be interpreted with the level of neutrophil response. “Response” > 0.5 has a negative predictive value; the EAA < 0.6 at “Response” < 0.5 may indicate a high level of endotoxaemia.
format Online
Article
Text
id pubmed-5405379
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-54053792017-05-09 The Level of Oxidative Neutrophil Response When Determining Endotoxin Activity Assay: A New Biomarker for Defining the Indications and Effectiveness of Intensive Care in Patients with Sepsis Yaroustovsky, Michael Rogalskaya, Ekaterina Plyushch, Marina Klimovich, Ludmila Samsonova, Nataliya Abramyan, Marina Int J Inflam Research Article Background. To analyse the clinical informativity of the neutrophil oxidative response level (“Response”) during an Endotoxin Activity Assay (EAA) as a new biomarker defining the indications and effectiveness of intensive care in cardiac surgical patients with septic complications. Methods. Blood samples were taken from 198 adult patients who were admitted to the ICU after cardiac surgery (SIRS: 34, MODS: 36, and sepsis: 128). The composite of laboratory studies included CRP, PCT, EAA with “Response” level, and presepsin. Results. 83% of patients had a “normal” neutrophil response, 12% of patients had a low neutrophil response, and 5% of patients had a critically low neutrophil response. Patients with critically low responses had the lowest values of the EAA and the highest concentrations of PSP and D-dimer (p < 0.05). Conclusions. EAA results should be interpreted with the level of neutrophil response. “Response” > 0.5 has a negative predictive value; the EAA < 0.6 at “Response” < 0.5 may indicate a high level of endotoxaemia. Hindawi 2017 2017-04-12 /pmc/articles/PMC5405379/ /pubmed/28487809 http://dx.doi.org/10.1155/2017/3495293 Text en Copyright © 2017 Michael Yaroustovsky et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yaroustovsky, Michael
Rogalskaya, Ekaterina
Plyushch, Marina
Klimovich, Ludmila
Samsonova, Nataliya
Abramyan, Marina
The Level of Oxidative Neutrophil Response When Determining Endotoxin Activity Assay: A New Biomarker for Defining the Indications and Effectiveness of Intensive Care in Patients with Sepsis
title The Level of Oxidative Neutrophil Response When Determining Endotoxin Activity Assay: A New Biomarker for Defining the Indications and Effectiveness of Intensive Care in Patients with Sepsis
title_full The Level of Oxidative Neutrophil Response When Determining Endotoxin Activity Assay: A New Biomarker for Defining the Indications and Effectiveness of Intensive Care in Patients with Sepsis
title_fullStr The Level of Oxidative Neutrophil Response When Determining Endotoxin Activity Assay: A New Biomarker for Defining the Indications and Effectiveness of Intensive Care in Patients with Sepsis
title_full_unstemmed The Level of Oxidative Neutrophil Response When Determining Endotoxin Activity Assay: A New Biomarker for Defining the Indications and Effectiveness of Intensive Care in Patients with Sepsis
title_short The Level of Oxidative Neutrophil Response When Determining Endotoxin Activity Assay: A New Biomarker for Defining the Indications and Effectiveness of Intensive Care in Patients with Sepsis
title_sort level of oxidative neutrophil response when determining endotoxin activity assay: a new biomarker for defining the indications and effectiveness of intensive care in patients with sepsis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405379/
https://www.ncbi.nlm.nih.gov/pubmed/28487809
http://dx.doi.org/10.1155/2017/3495293
work_keys_str_mv AT yaroustovskymichael thelevelofoxidativeneutrophilresponsewhendeterminingendotoxinactivityassayanewbiomarkerfordefiningtheindicationsandeffectivenessofintensivecareinpatientswithsepsis
AT rogalskayaekaterina thelevelofoxidativeneutrophilresponsewhendeterminingendotoxinactivityassayanewbiomarkerfordefiningtheindicationsandeffectivenessofintensivecareinpatientswithsepsis
AT plyushchmarina thelevelofoxidativeneutrophilresponsewhendeterminingendotoxinactivityassayanewbiomarkerfordefiningtheindicationsandeffectivenessofintensivecareinpatientswithsepsis
AT klimovichludmila thelevelofoxidativeneutrophilresponsewhendeterminingendotoxinactivityassayanewbiomarkerfordefiningtheindicationsandeffectivenessofintensivecareinpatientswithsepsis
AT samsonovanataliya thelevelofoxidativeneutrophilresponsewhendeterminingendotoxinactivityassayanewbiomarkerfordefiningtheindicationsandeffectivenessofintensivecareinpatientswithsepsis
AT abramyanmarina thelevelofoxidativeneutrophilresponsewhendeterminingendotoxinactivityassayanewbiomarkerfordefiningtheindicationsandeffectivenessofintensivecareinpatientswithsepsis
AT yaroustovskymichael levelofoxidativeneutrophilresponsewhendeterminingendotoxinactivityassayanewbiomarkerfordefiningtheindicationsandeffectivenessofintensivecareinpatientswithsepsis
AT rogalskayaekaterina levelofoxidativeneutrophilresponsewhendeterminingendotoxinactivityassayanewbiomarkerfordefiningtheindicationsandeffectivenessofintensivecareinpatientswithsepsis
AT plyushchmarina levelofoxidativeneutrophilresponsewhendeterminingendotoxinactivityassayanewbiomarkerfordefiningtheindicationsandeffectivenessofintensivecareinpatientswithsepsis
AT klimovichludmila levelofoxidativeneutrophilresponsewhendeterminingendotoxinactivityassayanewbiomarkerfordefiningtheindicationsandeffectivenessofintensivecareinpatientswithsepsis
AT samsonovanataliya levelofoxidativeneutrophilresponsewhendeterminingendotoxinactivityassayanewbiomarkerfordefiningtheindicationsandeffectivenessofintensivecareinpatientswithsepsis
AT abramyanmarina levelofoxidativeneutrophilresponsewhendeterminingendotoxinactivityassayanewbiomarkerfordefiningtheindicationsandeffectivenessofintensivecareinpatientswithsepsis